Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BFRI stock hub

Biofrontera Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BFRIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BFRI

In the news

Latest news · BFRI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-141.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-54.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BFRI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001858685
Company name	Biofrontera Inc.
Country	United States
Country code	US
Cusip	09077D100
Employees	94
Employees Change	1%
Employees Change Percent	1.08
Enterprise value	$13.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2021-10-29
Isin	US09077D2099
Last refreshed	2026-05-10
Market cap	$13.4M
Market cap category	Nano-Cap
Price	$1.15
Price currency	USD
Rev Per Employee	443,670.21x
Sector	Healthcare
Sic	2834
Symbol	BFRI
Website	https://www.biofrontera-us.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-78.65%
EV Sales Forward	0.28x
EV/Sales	0.32x
FCF yield	-99.76%
P/B ratio	1.28x
P/S ratio	0.32x
PS Forward	0.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-27.21%
EBITDA Margin	-26.88%
Gross margin	73.71%
Gross Profit	$30.7M
Gross Profit Growth	64.27%
Gross Profit Growth Q	93.37%
Gross Profit Growth3 Y	31.6%
Gross Profit Growth5 Y	25.73%
Net Income	$-10.5M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-25.2%
Profit Margin	-25.26%
Profit Per Employee	$-112,085
ROA	-28
Roa5y	-30.86
ROCE	-68.08
ROE	-141.3
Roe5y	-221.9
ROIC	-54.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	63.94%
Cagr3y	-54.17%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth	11.75x
Revenue Growth Q	36.16x
Revenue Growth Quarters	1x
Revenue Growth Years	5x
Revenue Growth3 Y	13.3x
Revenue Growth5 Y	17.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.65
Assets	$28.6M
Cash	$6.4M
Current Assets	$18.1M
Current Liabilities	$11.9M
Debt	$6.2M
Debt Equity	$0.59
Equity	$10.5M
Interest Coverage	-25.11
Liabilities	$18.1M
Long Term Assets	$10.5M
Long Term Liabilities	$6.2M
Net Cash	$240,000
Net Cash By Market Cap	$1.79
Net Cash Growth	-75.76%
Net Debt Equity	$-0.02
Tangible Book Value	$7.8M
Tangible Book Value Per Share	$0.67
WACC	8.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Inventory Turnover	2.72
Net Working Capital	$119,000
Quick ratio	1.31
Working Capital	$6.2M
Working Capital Turnover	$5.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-84.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	63.89%
200-day SMA	0.92
3Y total return	-90.38%
50-day SMA	0.97
50-day SMA vs 200-day SMA	50over200
All Time High	292.6
All Time High Change	-99.61%
All Time High Date	2021-12-21
All Time Low	0.54
All Time Low Change	114.55%
All Time Low Date	2025-05-30
ATR	0.06
Beta	0.91
Beta1y	1.47
Beta2y	0.85
Ch YTD	101.8
High	1.16
High52	1.19
High52 Date	2026-05-06
High52ch	-3.36%
Low	1.12
Low52	0.54
Low52 Date	2025-05-30
Low52ch	114.55%
Ma50ch	18.58%
Price vs 200-day SMA	25.04%
RSI	65.44
RSI Monthly	34.36
RSI Weekly	63.43
Sharpe ratio	0.96x
Sortino ratio	1.77
Total Return	-84.4%
Tr YTD	101.8
Tr1m	17.35%
Tr1w	6.48%
Tr3m	40.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	10,100,000x
Earnings Revenue Estimate Growth	17.61x
Operating Income	$-11.3M
Operating margin	-27.21
Price target	$2.75
Price Target Change	$139

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,948,217%
Float Percent	68.23%
Shares Insiders	10.68%
Shares Institutions	5.49%
Shares Out	11,648,323
Shares Qo Q	8.24%
Shares Yo Y	84.4%
Short Float	0.91%
Short Ratio	0.55
Short Shares	0.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-14.3M
Average Volume	135,652.5x
Bv Per Share	0.9
CAPEX	$-2,000
Ch1m	17.35
Ch1w	6.48
Ch1y	63.89
Ch3m	40.07
Ch3y	-90.38
Ch6m	6.48
Change	0.88%
Change From Open	0
Close	1.14
Days Gap	0.88
Depreciation Amortization	138,000
Dollar Volume	126,824.3
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-11.3M
EBITDA	$-11.2M
EPS	$-1.04
F Score	2
FCF	$-13.4M
FCF EV Yield	-101.58x
FCF Per Share	$-1.15
Financing CF	10,850,000
Fiscal Year End	December
Founded	1,997
Income Tax	$25,000
Investing CF	2,998,000
Ipr	-77
Iprfo	-98.59
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Date	2023-07-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	0.91
Ma150ch	25.82%
Ma20	1.1
Ma20ch	4.83%
Net CF	487,000
Next Earnings Date	2026-05-14
Open	1.15
Optionable	No
Position In Range	75
Post Close	1.15
Postmarket Change Percent	0.86
Postmarket Price	$1.16
Ppne	3,742,000
Price Date	2026-05-08
Ptbv Ratio	1.71
Relative Volume	0.81x
Revenue	41,705,000x
SBC By Revenue	2.28x
Share Based Comp	951,000
Tax By Revenue	0.06x
Tr6m	6.48%
Us State	Massachusetts
Volume	110,282
Z Score	-5.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BFRI pay a dividend?

Capital-return profile for this ticker.

Performance

BFRI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BFRI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.5%

Float: +68.2% of shares outstanding

Insider ownership

+10.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BFRI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.4

Neutral momentum band

Price vs 200-day MA

+25.0%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BFRI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BFRI stock rating?

Biofrontera Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BFRI analysis?

The full report lives at /stocks/BFRI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BFRI?

The latest report frames BFRI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BFRI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.